SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-024659
Filing Date
2012-04-18
Accepted
2012-04-18 20:51:18
Documents
1
Period of Report
2012-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd342429.html 4/A  
1 FORM 4/A rrd342429.xml 4/A 4274
  Complete submission text file 0001181431-12-024659.txt   5526
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-24274 | Film No.: 12767080